Free Trial
OTCMKTS:REED

Reeds (REED) Stock Price, News & Analysis

Reeds logo
$0.98 -0.02 (-1.80%)
As of 02:46 PM Eastern

About Reeds Stock (OTCMKTS:REED)

Advanced

Key Stats

Today's Range
$0.96
$0.98
50-Day Range
$0.88
$1.18
52-Week Range
$0.51
$1.93
Volume
3,561 shs
Average Volume
6,890 shs
Market Capitalization
$52.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.75
Consensus Rating
Buy

Company Overview

Reeds Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
59th Percentile Overall Score

REED MarketRank™: 

Reeds scored higher than 59% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Reeds has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Upside Potential

    Reeds has a consensus price target of $1.75, representing about 78.2% upside from its current price of $0.98.

  • Amount of Analyst Coverage

    Reeds has received no research coverage in the past 90 days.

  • Read more about Reeds' stock forecast and price target.
  • Earnings Growth

    Earnings for Reeds are expected to grow in the coming year, from ($1.22) to ($0.09) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Reeds is -0.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Reeds is -0.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Reeds has a P/B Ratio of 7.01. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.04% of the outstanding shares of Reeds have been sold short.
  • Short Interest Ratio / Days to Cover

    Reeds has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Reeds has recently decreased by 24.64%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Reeds does not currently pay a dividend.

  • Dividend Growth

    Reeds does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.04% of the outstanding shares of Reeds have been sold short.
  • Short Interest Ratio / Days to Cover

    Reeds has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Reeds has recently decreased by 24.64%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Reeds has a news sentiment score of -0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Consumer Staples companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Reeds this week, compared to 6 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Reeds insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    88.00% of the stock of Reeds is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    51.48% of the stock of Reeds is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Reeds' insider trading history.
Receive REED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Reeds and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

REED Stock News Headlines

This Biotech has a clinical approach that intrigues investors
This biotech is gearing up for Phase 2 trials with a strategy to unlock multiple approvals from one study. Basket trials test a single drug across several rare diseases, saving time and multiplying upside. More shots on goal means more chances to win. It's a smart setup - designed by a PROVEN team with a $680M exit already - to reduce risk and accelerate potential progress across multiple indications.tc pixel
See More Headlines

REED Stock Analysis - Frequently Asked Questions

Reeds' stock was trading at $0.6252 at the start of the year. Since then, REED shares have increased by 57.1% and is now trading at $0.9820.

Reeds, Inc. (OTCMKTS:REED) posted its quarterly earnings results on Tuesday, August, 12th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by $0.06. The business had revenue of $9.52 million for the quarter, compared to the consensus estimate of $10.29 million.
Read the conference call transcript
.

Shares of REED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Reeds investors own include Avino Silver & Gold Mines (ASM), Sorrento Therapeutics (SRNE), Ampio Pharmaceuticals (AMPE), Trevena (TRVN), 22nd Century Group (XXII), Navidea Biopharmaceuticals (NAVB) and TherapeuticsMD (TXMD).

Company Calendar

Last Earnings
8/12/2025
Today
10/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
BEVERAGES - SOFT
Sub-Industry
Candy & Soda
Current Symbol
OTCMKTS:REED
Previous Symbol
NYSE:REED
CIK
1140215
Employees
30
Year Founded
1987

Price Target and Rating

High Price Target
$1.75
Low Price Target
$1.75
Potential Upside/Downside
+78.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.22)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$13.15 million
Net Margins
-43.28%
Pretax Margin
-45.36%
Return on Equity
N/A
Return on Assets
-69.61%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.03
Quick Ratio
0.41

Sales & Book Value

Annual Sales
$37.95 million
Price / Sales
1.39
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.14 per share
Price / Book
7.02

Miscellaneous

Outstanding Shares
53,670,000
Free Float
6,441,000
Market Cap
$52.77 million
Optionable
Not Optionable
Beta
0.18

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (OTCMKTS:REED) was last updated on 10/2/2025 by MarketBeat.com Staff
From Our Partners